NCT07310056Recruiting
The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
Source: ClinicalTrials.gov · Last updated 9 Sept 2026
Brief summary (registry, in English)
This study aims to develop and evaluate an integrated perioperative management system based on wearable devices and a digital rehabilitation platform for patients with non-small cell lung cancer (NSCLC) undergoing thoracic surgery. By combining preoperative functional assessment using the six-minute walk test (6MWT), continuous perioperative physiological monitoring, and structured postoperative home-based digital rehabilitation, this randomized controlled trial will investigate whether the wearable-based digital management model improves short-term postoperative pulmonary function, functional recovery, and clinical outcomes compared with standard perioperative care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- First submitted
- 30 Nov 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- West China Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07310056
What you commit to
- Study type: Interventional
- Planned participants: 126
- From 1 Jan 2026 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Preoperative long-term home oxygen therapy or severe resting respiratory failure
- Presence of severe or uncontrolled cardiopulmonary disease, cerebrovascular disease, hepatic insufficiency, or renal insufficiency
- Severe comorbid conditions that significantly limit physical activity or adherence to rehabilitation
- Known or suspected allergy to materials used in wearable devices or medical adhesives
- Any other condition that, in the judgment of the investigators, makes the participant unsuitable for study participation
Who the study is looking for
- Age ≥18 years and ≤85 years
- Pathologically confirmed primary non-small cell lung cancer (NSCLC)
- Scheduled to undergo elective curative-intent thoracoscopic lobectomy or segmentectomy
- Able to independently operate a smartphone and wearable device, or able to do so with caregiver assistance
- Willing to comply with study procedures and follow-up requirements
- Provided written informed consent prior to participation
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| West China Hospital Coordinator of this site? Confirm its status | Chengdu | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.